NCT02916953 - CONFIRM - Study of AGN1 LOEP in Patients With Osteoporosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 17, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

April 30, 2022

Conditions

Osteoporosis

Interventions

DEVICE

AGN1 Femoral Local Osteo-Enhancement Procedure

A procedure that is intended to increase the strength of the proximal femur in individuals with osteoporosis of the femoral neck. Local treatment of the proximal femur with AGN1 is intended to be adjunctive to appropriate systemic therapy and overall osteoporosis management as directed by the patient's treating physicians.

Trial Locations (5)

6229

Maastricht UMC, Maastricht

8500

AZ Groeninge - Campus Kennedylaan, Kortrijk

9000

AZ Maria Middelares, Ghent

9110

AZ Sint-Nikolaas, Sint-Niklaas

9200

AZ Sint-Blasius, Dendermonde

All Listed Sponsors

collaborator

KCR S.A.

UNKNOWN

collaborator

genae Group

UNKNOWN

lead

AgNovos Healthcare, LLC

INDUSTRY